Business
Adia Med Enters $1.9 Billion Glutathione Industry with Innovative IV and Transdermal Therapies, Expanding High-Demand Offerings
Winter Park, Florida--(Newsfile Corp. - August 6, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), a rising leader in regenerative medicine, is excited to announce that its subsidiary, Adia Med, is now incorporating glutathione IV therapies into select treatment protocols at its state-of-the-art clinics. In a complementary move, Adia Labs has introduced Glutaryl Transdermal Glutathione Spray, an innovative product leveraging the antioxidant properties of glutathione, often referred to as the body's "
About this update from Adia Nutrition, Inc.
[{"type":"text","content":"Winter Park, Florida--(Newsfile Corp. - August 6, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), a rising leader in regenerative medicine, is excited to announce that its subsidiary, Adia Med, is now incorporating glutathione IV therapies into select treatment protocols at its state-of-the-art clinics. In a complementary move, Adia Labs has introduced Glutaryl Transdermal Glutathione Spray, an innovative product leveraging the antioxidant properties of glutathione, often referred to as the body's "master antioxidant".","length":534,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":550,"height":540,"url":"https://media.zenfs.com/en/newsfile_64/31f222644958ee1f1ca1f4268834ad85"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Mnq7l6LGekBNEPblNCV9yQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk0MztjZj13ZWJw/https://media.zenfs.com/en/newsfile_64/31f222644958ee1f1ca1f4268834ad85","width":550,"height":540}},"href":"https://images.newsfilecorp.com/files/10520/261150_glutaryl_topical_glutathione.jpg","hrefExternal":true},{"type":"text","content":"Glutaryl Topical Glutathione","length":28,"tagName":"p","attribs":{}},{"type":"text","content":"To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/261150_glutaryl_topical_glutathione.jpg","length":142,"tagName":"p","attribs":{}},{"type":"text","content":"Adia Med has integrated glutathione IV therapies into its regenerative medicine protocols, which include cutting-edge stem cell and exosome treatments like Adia Vita (100 million stem cells, 3 trillion exosomes) for a variety of conditions including orthopedics, pain management, and wound repair. Glutathione, a naturally occurring tripeptide, supports cellular health and detoxification, making it a valuable addition to Adia Med's holistic approach to patient care. Administered intravenously, these therapies ensure optimal absorption, complementing existing treatments that have shown success. This expansion reflects Adia Med's commitment to meeting the evolving needs of patients seeking innovative, science-backed solutions.","length":740,"tagName":"p"},{"type":"text","content":"Adia Labs' Glutaryl Transdermal Spray utilizes advanced sub-nanotechnology to enhance skin abs...